There has been increasing research momentum to identify new therapeutic agents for the
prevention or treatment of preeclampsia, drugs that can affect the underlying disease …

As one of the leading causes of premature birth and maternal and infant mortality worldwide,
preeclampsia remains a major unmet public health challenge. Preeclampsia and related …

Preeclampsia is a complex disease affecting 2–8% of pregnancies worldwide. It poses
significant risk of maternal and perinatal morbidity and mortality. Despite the rising research …

Preeclampsia is a hypertensive disorder of pregnancy with a high rate of maternal and
neonatal morbidity and mortality. The only definite treatment is delivery. Preclinical …

The aim of this study was to investigate the possible protective effects of apelin, which is
known to have antioxidant and anti-inflammatory effects, on changes in neurogenesis in …

We provide an updated framework of the current approaches to define and diagnose
preeclampsia. Disease modifying therapies (in particular, targeting the angiogenic pathway) …

Preeclampsia (PE) is a pregnancy-specific hypertensive disorder with end-organ damage
that presents after 20 wk of gestation. PE pathophysiology often includes vascular …

Gastroesophageal reflux disease (GERD) is frequently seen during pregnancy. In the
medical treatment of pregnant women with GERD, alginic acid and sucralfate can be used …

Objective This study aimed to determine whether receiving a proton-pump inhibitor (PPI)
prescription during pregnancy was associated with decreased risk for preeclampsia. Study …

Background: Preeclampsia is one of the most serious complications of pregnancy, leading to
various maternal and fetal complications. Objectives: This study aimed to determine the …